FRANCES DY: Open Payments
NPI 1629531686 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,931 in 27 payments from 6 companies in 2025. Trend: 2023 $12,540 · 2024 $25,397 · 2025 $16,931
Speaker / faculty: $14,990Food & beverage: $1,034Consulting: $706Education: $126Travel & lodging: $75
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 18 | $14,526 |
| Merck Sharp & Dohme LLC | 5 | $1,621 |
| United Therapeutics Corporation | 1 | $506 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $200 |
| Johnson & Johnson Health Care Systems Inc. | 1 | $56 |
| Baxter Healthcare | 1 | $21 |
Products named: UPTRAVI, WINREVAIR, Adempas, OPSUMIT, FLOSEAL.
Industry payments across CA — which companies pay providers there.
